ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Alfasigma acquires the European license for bentracimab from PhaseBio prnasia
June 22, 2021Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc., for the commercialization of bentracimab in 49 countries across Europe and other key markets. -
Alfasigma: It's Vein Week from 5th to 11th of April prnasia
April 01, 2021Venous-lymphatic World International Network foundation (v-WIN), a no profit global organization dedicated to research and education in the venous & lymphatic field has developed a public and health professional awareness not-for-profit project called ...
Pharma Sources Insight January 2025
